Clinical Trial Update: Efficacy Assessment of Systematic Treatment With Folinic Acid and Thyroid Hormone on Psychomotor Development of Down Syndrome Young Children [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing folinic acid and thyroid hormone treatment for psychomotor development in young children with Down syndrome has completed; results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome

Drugs mentioned

• Folinic acid (folinic acid)
• Thyroid hormone

Snippet

Sponsor: Institut Jerome Lejeune | Conditions: Down Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2020-05-13